Last updated: August 12, 2025
Introduction
South Korea's patent KR20110038725 pertains to drug-related inventions, emphasizing pharmaceutical compounds, formulations, methods of use, or manufacturing processes. As one of the key jurisdictions for pharmaceutical patent protection in Asia, understanding the scope, claims, and landscape of this patent is essential for stakeholders involved in drug development, licensing, or patent strategy.
Patent Overview and Timeline
- Filing Date: March 16, 2011
- Publication/Grant Date: The patent was published on March 28, 2012, with subsequent maintenance and legal events following.
- Applicant/Holder: Korean Intellectual Property Office (KIPO) records list the applicant as a pharmaceutical entity—exact assignee details require further patent documentation review.
Scope of the Patent
The scope of KR20110038725 encapsulates inventions related to pharmaceutical compounds with specified chemical structures, their uses, and associated formulations. Typically, patents of this nature aim to protect:
- Novel chemical entities: Structural innovations aimed at treating specific conditions, such as metabolic disorders, cancer, or infectious diseases.
- Pharmaceutical formulations: Methods for administering the active compound, including dosage forms and delivery systems.
- Methods of use: Therapeutic methods leveraging the compound's efficacy.
- Manufacturing processes: Techniques for synthesizing or stabilizing the drug substance.
The precise scope can be assessed through the patent's claims section, which delineates the boundaries of protection.
Claims Analysis
The patent contains multiple claims, generally subdivided into independent and dependent claims:
1. Independent Claims
- Chemical compound claims: Cover structures with particular substituents or functional groups, providing a broad scope for derivatives or analogs.
- Methods of synthesis: Claims covering specific synthetic routes, potentially blocking competitors from using alternative synthesis approaches.
- Therapeutic use claims: Claims covering the compounds' use in treating particular diseases or conditions, expanding the patent's protective reach to medical indications.
2. Dependent Claims
- Narrow down the scope, specifying particular substituents, dosages, formulations, or modes of administration, providing fallback positions if the broader claims are challenged.
Legal and Strategic Implications of the Claims
The patent's broad chemical structure claims serve as a robust barrier, preventing competitors from developing similar derivatives within the scope. Use claims offer protection over specific therapeutic applications, which can be crucial if the chemical claim scope is narrowed during litigation or examination.
Furthermore, claims directed towards manufacturing processes can protect production methods, potentially deterring process-innovation challenges from competitors.
Patent Landscape Context in South Korea
South Korea maintains a vibrant patent environment, especially for pharmaceuticals, governed by stringent criteria under the Korean Patent Act. Competitive landscape considerations include:
- Overlap with other patents: Similar compounds or methods may be filed by local or international companies, creating a crowded patent space.
- Patent validity and prosecution history: Office actions, claim amendments, and prior art rejections impact the enforceability and scope.
- Patent term and supplementary protection: Patent protection is valid for 20 years from the filing date, subject to maintenance fees, with potential extensions for pharmaceutical products.
In the context of KR20110038725, the landscape includes:
- Prior art references relating to similar chemical structures or uses, potentially limiting the scope.
- Subsequent filings of follow-up patents or improvements by either the applicant or competitors, forming a complex patent thicket.
- Regulatory exclusivities that may complement patent protection.
Patent Family and Related Filings
Investigating family members reveals whether the patent has:
- International counterparts: Filed via the Patent Cooperation Treaty (PCT), providing broader geographical protection.
- Divisional or continuation applications: Covering alternative claims or specific embodiments.
- National phase entries: In jurisdictions like China, Japan, or the US, expanding the scope of protection.
This comprehensive view influences licensing strategies, patent enforcement, and R&D planning.
Challenges and Opportunities
Challenges:
- Narrow claim scope: If claims are narrowly drafted, competitors might exploit design around strategies.
- Legal challenges: Patent validity may be challenged based on prior art or inventive step considerations.
- Patent expiry: Upcoming expiration dates could open the market for generics.
Opportunities:
- Patent enforcement: As a key Asian jurisdiction, South Korea provides a strategic base for regional enforcement.
- Life cycle management: Supplementary patents or patent term extensions can prolong exclusivity.
- Collaborative licensing: Patent strength facilitates partnerships with local or global pharmaceutical companies.
Conclusion
The patent KR20110038725 encompasses a robust intellectual property framework protecting specific chemical entities, their formulations, and uses within South Korea. Its broad scope, particularly in chemical and therapeutic claims, offers significant market defenses. The patent landscape surrounding this patent is dynamic, with active competition and ongoing patent filings shaping its enforceability and strategic value.
Key Takeaways
- The scope of KR20110038725 primarily covers novel pharmaceutical compounds and related methods, with claims likely emphasizing chemical structure and use.
- Strategic importance lies in its broad chemical and therapeutic claims, offering protection over derivatives and formulations.
- The South Korean patent landscape in pharmaceuticals is highly active, with overlapping patents and patent families influencing freedom to operate.
- Success depends on maintaining patent strength through continuous prosecution, monitoring competitors, and leveraging patent rights for licensing or enforcement.
- Recognizing potential challenges like claim narrowing or prior art is vital for effective patent management and commercialization plans.
FAQs
1. What is the primary protective scope of KR20110038725?
It generally covers specific chemical compounds, their therapeutic use, and manufacturing methods, aiming to block competitors from developing similar drugs within the defined parameters.
2. How does South Korea's patent landscape impact this patent?
South Korea's active pharmaceutical patent environment necessitates vigilant monitoring of overlapping patents and patent family filings to ensure freedom to operate and strategic licensing opportunities.
3. Can this patent be extended beyond 20 years?
Standard patent term is 20 years from the filing date. Extension possibilities exist through regulatory or supplementary patent protections, depending on jurisdictional regulations.
4. What threats could weaken the patent's enforceability?
Challenges include prior art invalidating claims, narrow claim scope allowing design-around strategies, or legal challenges based on inventive step or novelty.
5. How does this patent influence licensing and commercialization?
A strong patent provides leverage for licensing negotiations, partnership development, and market exclusivity, especially in South Korea and potentially in regional markets through patent family extensions.
References
- Korean Intellectual Property Office (KIPO) Patent Database: KR20110038725
- Korean Patent Act and Procedure Guidelines
- World Intellectual Property Organization (WIPO): Patent Landscape Reports for Pharmaceuticals
